Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Characterization of recombinant human mitochondrial processing peptidase
EF 2016-17
Résumé
The vast majority of mitochondrial proteins are synthesized in the cytosol and must be transported into the mitochondria. These proteins are targeted by a short signal peptide which must be removed once they are at the mitochondrial membrane. This removal is essential for proper folding and function and is carried out by one protein in the mitochondrial matrix: mitochondrial processing peptidase (MPP). Mutations in both MPP and its substrates have been implicated in various neurodegenerative diseases, including Parkinson's disease (PD) and non-progressive cerebellar ataxia. One of these implicated substrates is PINK1, a protein that acts as a sensor of mitochondrial health and whose mutations are known to cause early onset autosomal PD. It has been shown that PINK1 cleavage by MPP is necessary for its function, but the exact MPP cleavage site remains unknown, along with how PINK1 binds to MPP. These are two critical, unanswered questions that underlie the role of MPP in mitochondrial quality control. This project aims to answer these questions and provide a platform for assessing the mechanisms of MPP processing in a wide range of substrates. We will express and purify recombinant human MPP in E. coli, reconstitute its catalytic activity, characterize PINK1 binding, and determine the full MPP structure. First, this will lay the foundation for designing small molecule inhibitors of MPP. These inhibitors will provide an instrumental tool for studying the import and regulation of mitochondrial proteins in cells. This research will also shed light on the underlying molecular mechanisms of MPP-mediated quality control and provide crucial insight into the MPP processing cascade of PINK1 and other substrates.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
367050
Name
Bayne Andrew
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Characterization of recombinant human mitochondrial processing peptidase
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Mitochondria; Mitochondrial Processing Peptidase; Mitochondrial Quality Control; Mitophagy; Mpp; Neurodegeneration; Parkinson'S Disease; Pink1 Proteolysis; Protein Import; Structural Biology
Abstract
The vast majority of mitochondrial proteins are synthesized in the cytosol and must be transported into the mitochondria. These proteins are targeted by a short signal peptide which must be removed once they are at the mitochondrial membrane. This removal is essential for proper folding and function and is carried out by one protein in the mitochondrial matrix: mitochondrial processing peptidase (MPP). Mutations in both MPP and its substrates have been implicated in various neurodegenerative diseases, including Parkinson's disease (PD) and non-progressive cerebellar ataxia. One of these implicated substrates is PINK1, a protein that acts as a sensor of mitochondrial health and whose mutations are known to cause early onset autosomal PD. It has been shown that PINK1 cleavage by MPP is necessary for its function, but the exact MPP cleavage site remains unknown, along with how PINK1 binds to MPP. These are two critical, unanswered questions that underlie the role of MPP in mitochondrial quality control. This project aims to answer these questions and provide a platform for assessing the mechanisms of MPP processing in a wide range of substrates. We will express and purify recombinant human MPP in E. coli, reconstitute its catalytic activity, characterize PINK1 binding, and determine the full MPP structure. First, this will lay the foundation for designing small molecule inhibitors of MPP. These inhibitors will provide an instrumental tool for studying the import and regulation of mitochondrial proteins in cells. This research will also shed light on the underlying molecular mechanisms of MPP-mediated quality control and provide crucial insight into the MPP processing cascade of PINK1 and other substrates.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Bayne, Andrew
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~